ChemoMetec AS (OCSE:CHEMM) Cash Flow for Dividends: kr-121.8 Mil (TTM As of Dec. 2025)


OCSE:CHEMM ChemoMetec AS OCSE:CHEMM
99 GF Score
Price kr370.60
GF Value kr523.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is ChemoMetec AS Cash Flow for Dividends?

ChemoMetec AS OCSE:CHEMM +0.38% 99 Cash Flow for Dividends is kr-121.8 Mil as of Dec. 2025. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ChemoMetec AS's cash flow for dividends for the six months ended in Dec. 2025 was kr-121.8 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was kr-121.8 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

ChemoMetec AS's quarterly payment of dividends declined from Dec. 2024 (kr-69.6 Mil) to Jun. 2025 (kr0.0 Mil) but then increased from Jun. 2025 (kr0.0 Mil) to Dec. 2025 (kr-121.8 Mil).

ChemoMetec AS's annual payment of dividends increased from Jun. 2023 (kr0.0 Mil) to Jun. 2024 (kr-104.4 Mil) but then declined from Jun. 2024 (kr-104.4 Mil) to Jun. 2025 (kr-69.6 Mil).

ChemoMetec AS Cash Flow for Dividends Related Terms

ChemoMetec AS Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for ChemoMetec AS's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS Cash Flow for Dividends Chart

ChemoMetec AS Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.10 -69.61 0.00 -104.42 -69.60

ChemoMetec AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.42 0.00 -69.60 0.00 -121.82
OCSE:CHEMM
99GF Score
ChemoMetec AS OCSE:CHEMM
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ChemoMetec AS Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-121.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of kr-121.8 Mil mean?
ChemoMetec AS (OCSE:CHEMM) has a Cash Flow for Dividends of kr-121.8 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for ChemoMetec AS and its competitors.
Is ChemoMetec AS's Cash Flow for Dividends too high?
ChemoMetec AS's current Cash Flow for Dividends is kr-121.8 Mil. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Cash Flow for Dividends compare to ABT and SYK?
ChemoMetec AS's Cash Flow for Dividends of kr-121.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for ChemoMetec AS and its competitors. ChemoMetec AS's current Cash Flow for Dividends is kr-121.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr370.60 — trading 29.2% below its estimated fair value. The current Cash Flow for Dividends is kr-121.8 Mil. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Cash Flow for Dividends is kr-121.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?

Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued. The current stock price of kr370.60 is trading 29.2% below its estimated GF Value™ of kr523.33. GuruFocus considers ChemoMetec AS to be Modestly Undervalued.

Key valuation signals for OCSE:CHEMM:

  • Cash Flow for Dividends: kr-121.8 Mil
  • GF Value™: kr523.33 vs. price of kr370.60 (29.2% below fair value)
  • GF Score™: 99/100 with 2 warning signs

No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ChemoMetec AS Business Description

Other Exchanges CHEMMc:UK0DZ0:UKCHY:Germany
Address Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score

Get the complete analysis for OCSE:CHEMM

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr370.60
Price
kr523.33
GF Value